<code id='8FE849DEF9'></code><style id='8FE849DEF9'></style>
    • <acronym id='8FE849DEF9'></acronym>
      <center id='8FE849DEF9'><center id='8FE849DEF9'><tfoot id='8FE849DEF9'></tfoot></center><abbr id='8FE849DEF9'><dir id='8FE849DEF9'><tfoot id='8FE849DEF9'></tfoot><noframes id='8FE849DEF9'>

    • <optgroup id='8FE849DEF9'><strike id='8FE849DEF9'><sup id='8FE849DEF9'></sup></strike><code id='8FE849DEF9'></code></optgroup>
        1. <b id='8FE849DEF9'><label id='8FE849DEF9'><select id='8FE849DEF9'><dt id='8FE849DEF9'><span id='8FE849DEF9'></span></dt></select></label></b><u id='8FE849DEF9'></u>
          <i id='8FE849DEF9'><strike id='8FE849DEF9'><tt id='8FE849DEF9'><pre id='8FE849DEF9'></pre></tt></strike></i>

          Home / fashion / leisure time

          leisure time


          leisure time

          author:fashion    Page View:91
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In